Publications by authors named "Justin S Lee"

Background: Egg-based inactivated quadrivalent seasonal influenza vaccine (eIIV4), cell culture-based inactivated quadrivalent seasonal influenza vaccine (ccIIV4), and recombinant haemagglutinin (HA)-based quadrivalent seasonal influenza vaccine (RIV4) have been licensed for use in the USA. In this study, we used antigen-specific serum proteomics analysis to assess how the molecular composition and qualities of the serological antibody repertoires differ after seasonal influenza immunisation by each of the three vaccines and how different vaccination platforms affect the HA binding affinity and breadth of the serum antibodies that comprise the polyclonal response.

Methods: In this comparative, prospective, observational cohort study, we included female US health-care personnel (mean age 47·6 years [SD 8]) who received a single dose of RIV4, eIIV4, or ccIIV4 during the 2018-19 influenza season at Baylor Scott & White Health (Temple, TX, USA).

View Article and Find Full Text PDF
Article Synopsis
  • * A survey of 643 infectious disease providers revealed that 74% had used advanced molecular testing recently, with 16S rRNA gene sequencing being the most common method employed.
  • * Major barriers to using these tests included the lack of national guidelines and high costs, but there's potential for improvement in clinical practice and public health with better access and clear protocols.
View Article and Find Full Text PDF
Article Synopsis
  • * The CDC's National SARS-CoV-2 Strain Surveillance (NS3) program analyzed SARS-CoV-2 samples to understand the evolution of these variants and their spike mutations from May 2021 to February 2023.
  • * The study found that some subvariants have significantly evaded neutralizing antibodies from post-vaccination sera, indicating a need for ongoing research to evaluate the effectiveness of current vaccines and inform future updates.
View Article and Find Full Text PDF

To better identify emerging or reemerging pathogens in patients with difficult-to-diagnose infections, it is important to improve access to advanced molecular testing methods. This is particularly relevant for cases where conventional microbiologic testing has been unable to detect the pathogen and the patient's specimens test negative. To assess the availability and utility of such testing for human clinical specimens, a literature review of published biomedical literature was conducted.

View Article and Find Full Text PDF

The surveillance and identification of emerging, reemerging, and unknown infectious disease pathogens is essential to national public health preparedness and relies on fluidity, coordination, and interconnectivity between public and private pathogen surveillance systems and networks. Developing a national sentinel surveillance network with existing resources and infrastructure could increase efficiency, accelerate the identification of emerging public health threats, and support coordinated intervention strategies that reduce morbidity and mortality. However, implementing and sustaining programs to detect emerging and reemerging pathogens in humans using advanced molecular methods, such as metagenomic sequencing, requires making large investments in testing equipment and developing networks of clinicians, laboratory scientists, and bioinformaticians.

View Article and Find Full Text PDF

The COVID-19 pandemic was accompanied by an unprecedented surveillance effort. The resulting data were and will continue to be critical for surveillance and control of SARS-CoV-2. However, some genomic surveillance methods experienced challenges as the virus evolved, resulting in incomplete and poor quality data.

View Article and Find Full Text PDF

Group A streptococcal strains potentially acquire new M protein gene types through genetic recombination (emm switching). To detect such variants, we screened 12,596 invasive GAS genomes for strains of differing emm types that shared the same multilocus sequence type (ST). Through this screening we detected a variant consisting of 16 serum opacity factor (SOF)-positive, emm pattern E, emm82 isolates that were ST36, previously only associated with SOF-negative, emm pattern A, emm12.

View Article and Find Full Text PDF
Article Synopsis
  • The CDC has been tracking SARS-CoV-2 variants, particularly the Omicron variant, through national genomic surveillance since December 2020, with a report summarizing trends from January 2022 to May 2023.
  • Throughout this period, various Omicron descendant lineages, such as BA.1.1, BA.2, and BA.5, rose and fell in prevalence, often correlating with spikes in COVID-19 cases.
  • By May 2023, the variant XBB.1.5 dominated, underscoring the ongoing evolution of variants and the necessity for genomic surveillance to aid in vaccine and therapeutic strategies.
View Article and Find Full Text PDF
Article Synopsis
  • A study estimated the effectiveness of two and three mRNA COVID-19 vaccine doses against symptomatic illness due to SARS-CoV-2 Delta and Omicron variants in adults seeking outpatient care between October 2021 and February 2022.
  • The research involved 3,847 participants and found that vaccine effectiveness (VE) against symptoms was significantly higher for three doses compared to two doses, especially during the Delta variant period.
  • The results indicated that the three-dose regimen offered substantial protection against symptomatic illness when the Omicron variant was predominant, reinforcing the recommendation for a third vaccine dose.
View Article and Find Full Text PDF

Spatially heterogeneous landscape factors such as urbanisation can have substantial effects on the severity and spread of wildlife diseases. However, research linking patterns of pathogen transmission to landscape features remains rare. Using a combination of phylogeographic and machine learning approaches, we tested the influence of landscape and host factors on feline immunodeficiency virus (FIV) genetic variation and spread among bobcats () sampled from coastal southern California.

View Article and Find Full Text PDF

Purpose: To report outcomes in patients with intrahepatic cholangiocarcinoma treated with yttrium-90 resin microspheres (transarterial radioembolization [TARE]) from a multicenter, prospective observational registry.

Materials And Methods: Ninety-five patients (median age, 67 years [interquartile range {IQR}, 59-74]; 50 men) were treated in 27 centers between July 2015 and August 2020. Baseline demographic characteristics included imaging findings, performance status, and previous systemic or locoregional treatments.

View Article and Find Full Text PDF

Objective: To determine whether modified K-12 student quarantine policies that allow some students to continue in-person education during their quarantine period increase schoolwide SARS-CoV-2 transmission risk following the increase in cases in winter 2020-2021.

Methods: We conducted a prospective cohort study of COVID-19 cases and close contacts among students and staff (n = 65,621) in 103 Missouri public schools. Participants were offered free, saliva-based RT-PCR testing.

View Article and Find Full Text PDF

Identifying drivers of transmission-especially of emerging pathogens-is a formidable challenge for proactive disease management efforts. While close social interactions can be associated with microbial sharing between individuals, and thereby imply dynamics important for transmission, such associations can be obscured by the influences of factors such as shared diets or environments. Directly-transmitted viral agents, specifically those that are rapidly evolving such as many RNA viruses, can allow for high-resolution inference of transmission, and therefore hold promise for elucidating not only which individuals transmit to each other, but also drivers of those transmission events.

View Article and Find Full Text PDF

Importance: Few studies have prospectively assessed SARS-CoV-2 community infection in children aged 0 to 4 years. Information about SARS-CoV-2 incidence and clinical and virological features in young children could help guide prevention and mitigation strategies.

Objective: To assess SARS-CoV-2 incidence, clinical and virological features, and symptoms in a prospective household cohort and to compare viral load by age group, symptoms, and SARS-CoV-2 lineage in young children, older children, and adults.

View Article and Find Full Text PDF

Background: Households are common places for spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We investigated factors associated with household transmission and acquisition of SARS-CoV-2.

Methods: Households with children age <18 years were enrolled into prospective, longitudinal cohorts and followed from August 2020 to August 2021 in Utah, September 2020 to August 2021 in New York City, and November 2020 to October 2021 in Maryland.

View Article and Find Full Text PDF
Article Synopsis
  • The ongoing evolution of SARS-CoV-2 has led to new variants that heighten the severity of the COVID-19 pandemic, classified as variants of concern or interest (VOC/VOI) due to their impact on vaccine effectiveness.
  • A study analyzing 14 different variants found varying levels of resistance to neutralization by antibodies from vaccinated individuals, with the Omicron variant being the most adept at evading these defenses.
  • Despite Omicron's escape ability, individuals who received a booster vaccination still showed moderate effectiveness in neutralizing this variant, reinforcing the importance of vaccination in combating COVID-19.
View Article and Find Full Text PDF

The widespread transmission and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) call for rapid nucleic acid diagnostics that are easy to use outside of centralized clinical laboratories. Here we report the development and performance benchmarking of Cas13-based nucleic acid assays leveraging lyophilised reagents and fast sample inactivation at ambient temperature. The assays, which we named SHINEv.

View Article and Find Full Text PDF
Article Synopsis
  • Genomic surveillance is essential for monitoring emerging SARS-CoV-2 variants, which can impact public health by affecting transmissibility and immune response.
  • Between June 2021 and January 2022, the CDC enhanced its data collection methods to provide more accurate estimates of variant proportions by utilizing public repositories and refining analysis techniques.
  • During this time, the Delta variant initially dominated infections but was quickly supplanted by the Omicron variant, which accounted for nearly all U.S. cases by January 2022, highlighting the need for ongoing surveillance in pandemic response.
View Article and Find Full Text PDF
Article Synopsis
  • A study explored the preference for saliva-based COVID-19 testing over nasal swabs among K-12 students, parents, teachers, and staff in Missouri schools during a surveillance investigation.
  • Out of 719 participants surveyed, over one-third who accepted the saliva test would have declined a nasal swab, with 51% of elementary school students (or their guardians) indicating a preference for saliva.
  • The findings suggest that implementing saliva testing could enhance participation in COVID-19 screening in schools, potentially aiding in controlling the spread of the virus.
View Article and Find Full Text PDF

At the start of the COVID-19 pandemic, the Centers for Disease Control and Prevention (CDC) designed, manufactured, and distributed the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel for SARS-CoV-2 detection. The diagnostic panel targeted three viral nucleocapsid gene loci (N1, N2, and N3 primers and probes) to maximize sensitivity and to provide redundancy for virus detection if mutations occurred. After the first distribution of the diagnostic panel, state public health laboratories reported fluorescent signal in the absence of viral template (false-positive reactivity) for the N3 component and to a lesser extent for N1.

View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic highlighted the urgent need for widespread and decentralized nucleic acid testing, especially for SARS-CoV-2 Variants of Concern (VOCs).
  • SHINEv2 is a new diagnostic tool that uses Cas13 technology, allowing for quick testing at room temperature with easy-to-use, lyophilized reagents.
  • In tests, SHINEv2 showed 50 times more sensitivity and 100% specificity compared to leading antigen tests, and can identify multiple VOCs in under 90 minutes without any special equipment.
View Article and Find Full Text PDF

SARS-CoV-2, the virus that causes COVID-19, is constantly mutating, leading to new variants (1). Variants have the potential to affect transmission, disease severity, diagnostics, therapeutics, and natural and vaccine-induced immunity. In November 2020, CDC established national surveillance for SARS-CoV-2 variants using genomic sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • * A pilot study in Springfield and St. Louis County, Missouri, during December 2020 examined the impact of these strategies on SARS-CoV-2 transmission in participating schools.
  • * Findings indicated that schools using COVID-19 mitigation strategies had lower virus transmission compared to the community, suggesting the importance of continuing these measures until more data is available.
View Article and Find Full Text PDF

sp. strain X0973 is a Gram-positive, weakly acid-fast, aerobic actinomycete obtained from a human abscess with NBRC 100433 as its closest phylogenetic neighbor. Here, we report using Illumina MiSeq and PacBio reads to assemble the complete and circular genome sequence of 3.

View Article and Find Full Text PDF

Bunyaviruses (Negarnaviricota: Bunyavirales) are a large and diverse group of viruses that include important human, veterinary, and plant pathogens. The rapid characterization of known and new emerging pathogens depends on the availability of comprehensive reference sequence databases that can be used to match unknowns, infer evolutionary relationships and pathogenic potential, and make response decisions in an evidence-based manner. In this study, we determined the coding-complete genome sequences of 99 bunyaviruses in the Centers for Disease Control and Prevention's Arbovirus Reference Collection, focusing on orthonairoviruses (family Nairoviridae), orthobunyaviruses (Peribunyaviridae), and phleboviruses (Phenuiviridae) that either completely or partially lacked genome sequences.

View Article and Find Full Text PDF